It had long been held as a traditional view that there
was little interplay between the immune system and the “immunoprivileged” central
nervous system (CNS). However, by the
early 1990s there had been studies showing that immune system cells (ie, T
cells) patrolled the healthy brain via specialized regions of the CNS (Svenningsson
1995, Hickey 1991), and over the past decade many advances have been made in
our understanding of neuro-immune interactions.
In the recent August edition of Nature Neuroscience, much
attention was focused on the role of the immune system in surveying the CNS, not
only during pathological and injurious circumstances, but during normal health
as well. Many articles in this
particular issue glean insight on situations where there is considerable
interaction between resident sentinels of the CNS and circulating immune
cells. Immense in scope and insight was
a wonderful review entitled Immune Surveillance in the Central Nervous
System by Shalina Ousman and Paul Kubes, which is the focus of this blog
post.
I highly recommend anyone interested in neuro-immune
interactions to check this review out. Given
the topic, it is dense with information and packs in quite a hefty amount of citations
for good measure (100 exactly for a 4+ page review). It would be difficult to condense all of the
themes of this review; I will attempt to cover some of the major themes as
illustrated by the most recent findings that have contributed to the
information contained in this review.
1) Microglia are
the first-responders to CNS immune responses. Microglia, in addition to playing important supporting
roles in the development, homeostasis, and function of neurons, are the
mediators of immune responses in the CNS.
Microglia share surface markers with hematoenously-derived macrophages
(Prinz 2011) and fate-mapping has revealed microglia derive from primitive
macrophages (Ginhoux 2010). In mice, microglial
progenitors can invade the CNS as early as ten days into development (Schulz
2012) and a subset have been shown to be derived from the bone marrow and enter
the brain after birth (Chen 2010). It
has been well-documented over the last decade that microglia possess all the
necessary tools to detect noxious stimuli and can release a plethora of cytokines,
interleukins, interferons, etc, which are vital to mounting a potent
inflammatory response.
2) Immune cells
can travel into and out of the CNS. Regions
characterized by a less stringently-controlled blood-brain barrier (BBB) have
been hypothesized to be entry sites for circulating immune cells, including
specialized zones of the choroid plexus (CP), the perivascular (Virchow-Robin)
space, and even directly though postcapillary venules. A subset of CD4+ T cells have been
implicated to target Epithelial V-like Antigen in CP epithelial cells (Wojcik
2011) while another subset of CD4+ T cells have been shown to enter
the CNS at the 5th lumbar level of the spinal cord in multiple
sclerosis models (Arima 2012). However,
there is controversy as to which types of immune cells regularly enter the CNS,
with various subtypes of lymphocytes having been implicated (Loeffler
2011). While their entry into the CNS can
be fervently discussed, it has also been shown that CNS-derived antigens can
drain to deep cervical lymph nodes, with one group finding that monocytes
injected into the brain reach lymphatic organs via the cribroid plate (Kaminski
2012).
3) Viral
infections reveal the overall neuro-immune response. When viral antigen is detected by microglia,
various antiviral responses can be initiated to activate the innate and
adaptive immune systems. Recognition of
herpes simplex virus 1 (HSV-1) by microglia cells via TLR2 or TLR9 results in
secretion of type I interferons, TNF, IL-15, and the chemokine CCL2, which
recruits macrophages (Conrady 2010).
Other viral infections, such as West Nile Virus (WNV), are recognized by
microglia via TLR7 and results in secretion of IL-23; this promotes the
infiltration of monocytes and macrophages, plus CD4+ T cells (Sitati
2006), CD8+ T cells (Shrestha 2006), and δγ T cells (Wang 2003). CXCL12-CXCR4 interactions have been shown to further
mediate CD8+ T cell entry (McCandless 2008, Zhang 2008), while it is
believed that CCR5 also mediates the traffic of leukocytes in WNV infection
(Glass 2005).
In summation, I apologize for the length of this post,
but do yourself a favor and read the review!
-All citations taken from the review
SS Ousman and P Kubes. Immune surveillance in the central nervous system. 15(8):1096-1101, Nat Neurosci. August 2012.
http://www.nature.com/neuro/journal/v15/n8/full/nn0812-1055.html
Thanks for finding that review. As we get into T cells (this week) we'll see, I think, that there are still some unsettled issues about the immune system and the brain. Here's a hypothetical: Imagine a new antigen was somehow delivered into the brain without ever appearing in the blood or any tissue. Would you make a response to it?
ReplyDeleteI don’t think you would make a response to the antigen since there are no decent antigen presenting cells in the brain that can stimulate T-cells to divide. Even though t-cells can get into the brain they cannot become activated without antigen presenting cells stimulating them. Maybe one way for you to make an immune response to this antigen is if it is able to cross the blood brain barrier into the rest of the body. An example where in antigen (myelin) that is only found in the brain could stimulate an immune response is if it the antigen was systemically introduced. During the lecture online for type 4 immunopathology Dr. Cohen, talked about a fellow who was cut by broken class that contained human brain samples. A few months later the individual developed progressive encephalopathy. This was due to the antigen myelin in the human brain tissue getting into the individual systemically and being taken up by dendritic cells. The dendritic cells then took the antigen to the lymph node where T-cells that recognized the antigen became activated. These activated t-cells were able to cross the blood brain barrier and attack the brain.
ReplyDeletePryce G, Male D and Sedgwich J. Antigen presentation in brain: brain endothelial cells are poor stimulator of T-cell proliferation. Immunology 1989. 207-212.
Perry V. Persistent pathogens in the parenchyma of the brain. Journal of NeuroVirology 2000. 6:S86-S89.